AnaptysBio
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $22,263 | $27,771 | $43,113 | $30,017 |
Gross Profit | 21,662 | 27,771 | 43,113 | 29,421 |
EBITDA | -18,384 | -27,539 | -3,785 | -16,842 |
EBIT | -18,985 | -28,145 | -4,386 | -17,438 |
Net Income | -38,630 | -39,329 | -21,784 | -32,851 |
Net Change In Cash | 22,263 | 27,771 | 43,113 | 30,017 |
Free Cash Flow | -40,283 | -10,735 | -66,935 | -10,125 |
Cash | 44,298 | 98,637 | 123,080 | 191,581 |
Basic Shares | 28,810 | 30,644 | 28,382 | 28,893 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $91,280 | $17,157 | $10,287 | $63,175 |
Gross Profit | 91,280 | 14,781 | 7,952 | -35,321 |
EBITDA | -92,744 | -143,164 | -105,257 | -55,706 |
EBIT | -95,141 | -145,540 | -107,592 | -57,796 |
Net Income | -145,231 | -163,619 | -128,724 | -57,193 |
Net Change In Cash | 91,280 | 17,157 | 10,287 | 63,175 |
Cost of Revenue | -424,421 | 245,213 | ||
Free Cash Flow | -135,695 | -121,607 | -73,951 | -47,286 |
Cash | 123,080 | 35,965 | 71,308 | 495,729 |
Basic Shares | 28,382 | 26,924 | 28,165 | 27,431 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$1.34 |
2025-03-31 | -$1.28 |
2024-12-31 | -$0.72 |
